Coles, Eissa Alfadil, Florian Fler, Andreas Husch, Sebastian Dupraz, Thorben Pietralla, Akihiro Narita, Max Schelski, Kevin C
Effect of GLP-1RA treatment on adhesion molecules and monocyte chemoattractant protein-1 in diabetic patients with atherosclerosis
In the multivariate stepwise regression analysis, only SD appeared to be correlated with d-ROMs ( = 0.430, p = 0.008) (adjusted multiple R 2 = 0.162)
After your first month of treatment, you can add the Precision Peptide Genetic Test ($99) to identify genetic pathways influencing your response to GLP-1 therapy and personalize your long-term approach
NCT03574597): A 59-month long, phase-3 trial is being conducted on 17,500 obese but healthy subjects with cardiovascular history (age 45 years), where subjects receive either weekly-once 2.4 mg s.c
Use only as directed by applicable labeling, your clinician, or Renew Republic Health instructions.